Tulavi Therapeutics has a total of 40 patents globally, out of which 5 have been granted. Of these 40 patents, more than 92% patents are active. The United States of America is where Tulavi Therapeutics has filed the maximum number of patents, followed by Australia and Canada. Parallelly, the United States of America seems to be the main focused R&D centre and also is the origin country of Tulavi Therapeutics.
Tulavi Therapeutics was founded in 2018. Tulavi Therapeutics is a biotechnology company that is dedicated to creating novel treatments for disorders mediated by the nervous system. The company’s approach is focused on creating treatments that go straight after the nerves in order to prevent and/or cure abnormal neural reflex arcs associated with peripheral and visceral diseases.
Do read about some of the most popular patents of Tulavi Therapeutics which have been covered by us in this article and also you can find Tulavi Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Tulavi Therapeutics patent portfolio.
How many patents does Tulavi Therapeutics have?
Tulavi Therapeutics has a total of 40 patents globally. These patents belong to 6 unique patent families. Out of 40 patents, 37 patents are active.
How Many Patents did Tulavi Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Tulavi Therapeutics Applications Filed | Tulavi Therapeutics Patents Granted |
| 2023 | 2 | 1 |
| 2022 | 6 | 2 |
| 2021 | 11 | 1 |
| 2020 | 1 | – |
| 2019 | 12 | – |
| 2018 | – | 1 |
| 2017 | 7 | – |
| 2016 | 1 | – |
How many Tulavi Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Tulavi Therapeutics File in Different Countries?
Countries in which Tulavi Therapeutics Filed Patents
| Country | Patents |
| United States Of America | 15 |
| Australia | 6 |
| Canada | 5 |
| Europe | 4 |
| China | 4 |
| Hong Kong (S.A.R.) | 2 |
Where are Research Centers of Tulavi Therapeutics Patents Located?
The Research Centers of TulaviTherapeuticsPatents is the United States of America.
10 Best Tulavi Therapeutics Patents
US9855317B2 is the most popular patent in the Tulavi Therapeutics portfolio. It has received 229 citations so far from companies like Cardionomic, and Cilag.
Below is the list of 10 most cited patents of Tulavi Therapeutics:
| Publication Number | Citation Count |
| US9855317B2 | 36 |
| US20180147260A1 | 12 |
| WO2019178564A1 | 10 |
| US20210187160A1 | 4 |
| US20210268271A1 | 3 |
| CN112118828A | 3 |
| US20210205501A1 | 2 |
| CN110035754A | 2 |
| CA3093923A1 | 2 |
| WO2021146330A1 | 2 |
What Percentage of Tulavi Therapeutics US Patent Applications Were Granted?
Tulavi Therapeutics (Excluding its subsidiaries) has filed 14 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 100%.
Below are the key stats of Tulavi Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Tulavi Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Knobbe Martens Olson & Bear Llp | 14 | 100% |
List of Tulavi Therapeutics patents
| Tulavi Therapeutics Patents | Title |
| US11446359B2 | Systems And Methods For Cardiac Plexus Neuromodulation |
| US11246879B2 | Methods, Agents, And Devices For Local Neuromodulation Of Autonomic Nerves |
| US11154547B2 | Treatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous System |
| US9855317B2 | Systems And Methods For Sympathetic Cardiopulmonary Neuromodulation |
| US20220409902A1 | Methods And Devices For Nerve Regeneration |
| US20220370345A1 | Methods, Agents, And Devices For Local Neuromodulation Of Autonomic Nerves |
| US20220280497A1 | Treatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous System |
| US20220096711A1 | Method Of Facilitating Nerve Growth |
| US20220054705A1 | Devices For In Situ Formed Nerve Caps And/Or Nerve Wraps |
| US20210361292A1 | Methods For In Situ Formed Nerve Cap With Rapid Release |
| US20210315587A1 | Methods And Devices For In Situ Formed Nerve Cap With Rapid Release |
| US20210268271A1 | Systems And Methods For Visceral Neuromodulation |
| US20210205501A1 | Systems And Methods For Gel-Based Neuromodulation |
| US20210187160A1 | Methods And Devices For In Situ Formed Nerve Cap |
| US20180147260A1 | Systems And Methods For Sympathetic Cardiopulmonary Neuromodulation |
| EP4090261A1 | Methods And Devices For In Situ Formed Nerve Cap With Rapid Release |
| EP3817786A4 | Methods And Devices For In Situ Formed Nerve Cap |
| EP3764990A4 | Systems And Methods For Gel-Based Neuromodulation |
| EP3478287A4 | Treatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous System |
| CN115361912A | Methods And Devices For In-Situ Formation Of Nerve Caps With Quick Release |
| CN112638437A | Methods And Devices For In Situ Formed Nerve Cap |
| CN112118828A | Systems And Methods For Gel-Based Neuromodulation |
| CN110035754A | Treatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous System |
| WO2023288218A1 | Methods And Devices For Nerve Regeneration |
| AU2017290353B2 | Treatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous System |
| AU2022252296A1 | Methods And Compositions For The Ablation Of Nerves |
| AU2023214230A1 | Treatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous System |
| AU2021207853A1 | Methods And Devices For In Situ Formed Nerve Cap With Rapid Release |
| AU2019299519A1 | Methods And Devices For In Situ Formed Nerve Cap |
| AU2019236300A1 | Systems And Methods For Gel-Based Neuromodulation |
| CA3210288A1 | Methods And Compositions For The Ablation Of Nerves |
| CA3163429A1 | Methods And Devices For In Situ Formed Nerve Cap With Rapid Release |
| CA3105343A1 | Methods And Devices For In Situ Formed Nerve Cap |
| CA3093923A1 | Systems And Methods For Gel-Based Neuromodulation |
| CA3031761A1 | Treatment Of Sepsis And Related Inflammatory Conditions By Local Neuromodulation Of The Autonomic Nervous System |
| HK40082864A | Methods And Devices For In Situ Formed Nerve Cap With Rapid Release |
| HK40049073A | Methods And Devices For In Situ Formed Nerve Cap |
| WO2022212562A1 | Methods And Compositions For The Ablation Of Nerves |
| WO2021146330A1 | Methods And Devices For In Situ Formed Nerve Cap With Rapid Release |
| WO2019178564A1 | Systems And Methods For Gel-Based Neuromodulation |
What are Tulavi Therapeutics key innovation segments?
What Technologies are Covered by Tulavi Therapeutics?
The chart below distributes patents filed by Tulavi Therapeutics